Divi's Laboratories

quarterly
yearly
ParticularsDec '22Mar '23Jun '23Sep '23Dec '23
Revenue1,8071,9741,8101,9531,902
Expenses1,3681,5061,3321,4891,412
EBITDA526.00555.00571.00559.00585.00
EBIT439.00468.00478.00465.00490.00
Profit Before Tax439.00468.00478.00464.00490.00
Net Profit310.00319.00345.00342.00358.00
Financial Ratios
Operating Profit Margin31.12%29.09%33.01%29.93%32.36%
Net Profit Margin18.34%16.72%19.94%18.31%19.80%
Earning Per Share (Diluted)11.7112.0112.9912.8913.50
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.8.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ